EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The gut microbiome is a significant risk factor for future chronic lung disease

Yang Liu, Shu Mei Teo, Guillaume Méric, Howard H F Tang, Qiyun Zhu, Jon G Sanders, Yoshiki Vázquez-Baeza, Karin Verspoor, Ville A Vartiainen, Pekka Jousilahti, Leo Lahti, Teemu Niiranen und 4 weitere

Journal of Allergy and Clinical Immunology · 2023-04 · 151 (4) · 943-952

DOI: 10.1016/j.jaci.2022.12.810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-04. Verfasst von Yang Liu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, Australia; Cambridge Baker Systems Genomics Initi…. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Pulmonary Disease, Chronic Obstructive, Asthma. Die Arbeit wurde bisher 71-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, British Heart Foundation, Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The gut-lung axis is generally recognized, but there are few large studies of the gut microbiome and incident respiratory disease in adults. OBJECTIVE: We sought to investigate the association and predictive capacity of the gut microbiome for incident asthma and chronic obstructive pulmonary disease (COPD). METHODS: Shallow metagenomic sequencing was performed for stool samples from a prospective, population-based cohort (FINRISK02; N = 7115 adults) with linked national administrative health register-derived classifications for incident asthma and COPD up to 15 years after baseline. Generalized linear models and Cox regressions were used to assess associations of microbial taxa and diversity with disease occurrence. Predictive models were constructed using machine learning with extreme gradient boosting. Models considered taxa abundances individually and in combination with other risk factors, including sex, age, body mass index, and smoking status. RESULTS: A total of 695 and 392 statistically significant associations were found between baseline taxonomic groups and incident asthma and COPD, respectively. Gradient boosting decision trees of baseline gut microbiome abundance predicted incident asthma and COPD in the validation data sets with mean area under the curves of 0.608 and 0.780, respectively. Cox analysis showed that the baseline gut microbiome achieved higher predictive performance than individual conventional risk factors, with C-indices of 0.623 for asthma and 0.817 for COPD. The integration of the gut microbiome and conventional risk factors further improved prediction capacities. CONCLUSIONS: The gut microbiome is a significant risk factor for incident asthma and incident COPD and is largely independent of conventional risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomePulmonary Disease, Chronic ObstructiveAsthmaAdultHumansProspective StudiesRisk Factors

Stichwörter der Autor:innen

COPDGutasthmametagenomicsmicrobiome

Autor:innen und Institutionen

  • Department of Clinical Pathology, Melbourne Medical School, The University of Melbourne, Melbourne, Australia; Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia. Elect…
  • Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia; Cambridge Baker Systems Genomics Initiative, Department of Public Health and Primary Care, University of Cambridge,…
  • Cambridge Baker Systems Genomics Initiative, Baker Heart and Diabetes Institute, Melbourne, Australia.
  • School of Life Sciences, Arizona State University, Tempe, Ariz; Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University, Tempe, Ariz.
  • Department of Ecology and Evolutionary Biology, Cornell University, Ithaca, NY.
  • Center for Microbiome Innovation, Jacobs School of Engineering, University of California San Diego, La Jolla, Calif.

Förderung

  • Wellcome Trust
  • British Heart Foundation
  • Department of Health
  • Medical Research Council
  • Chief Scientist Office
  • NIHR Cambridge Biomedical Research Centre

Zitieren

APA

Liu, Y., Teo, S. M., Méric, G., Tang, H. H. F., Zhu, Q., Sanders, J. G., Vázquez-Baeza, Y., Verspoor, K., Vartiainen, V. A., Jousilahti, P., Lahti, L., Niiranen, T., Havulinna, A. S., Knight, R., Salomaa, V., & Inouye, M. (2023). The gut microbiome is a significant risk factor for future chronic lung disease. Journal of Allergy and Clinical Immunology, 151(4), 943-952. https://doi.org/10.1016/j.jaci.2022.12.810

Vancouver

Liu Y, Teo SM, Méric G, Tang HHF, Zhu Q, Sanders JG, et al. The gut microbiome is a significant risk factor for future chronic lung disease. Journal of Allergy and Clinical Immunology. 2023;151(4):943-952. doi:10.1016/j.jaci.2022.12.810

BibTeX
@article{Liu2023,
  author = {Liu, Yang and Teo, Shu Mei and Méric, Guillaume and Tang, Howard H F and Zhu, Qiyun and Sanders, Jon G and Vázquez-Baeza, Yoshiki and Verspoor, Karin and Vartiainen, Ville A and Jousilahti, Pekka and Lahti, Leo and Niiranen, Teemu and Havulinna, Aki S and Knight, Rob and Salomaa, Veikko and Inouye, Michael},
  title = {The gut microbiome is a significant risk factor for future chronic lung disease},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  volume = {151},
  number = {4},
  pages = {943--952},
  doi = {10.1016/j.jaci.2022.12.810}
}
Kostenlos starten →